Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160 | 1,052 | 556 | 997 | 243 |
| Receivables | 307 | 274 | 436 | 305 | 39 |
| Inventories | N/A | N/A | 0 | 1 | 1 |
| Other current assets | 334 | 323 | 181 | 58 | 60 |
| TOTAL | $878 | $1,708 | $1,234 | $1,527 | $567 |
| Non-Current Assets | |||||
| PPE Net | 521 | 514 | 529 | 548 | 510 |
| Investments And Advances | 3,365 | 3,270 | 3,336 | 3,408 | 3,488 |
| Other Non-Current Assets | 2,164 | 1,913 | 2,042 | 1,968 | 1,375 |
| TOTAL | $6,050 | $5,697 | $5,906 | $5,923 | $5,374 |
| Total Assets | $6,928 | $7,405 | $7,140 | $7,450 | $5,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13 | 23 | 35 | 40 | 40 |
| Accounts payable and accrued liabilities | 450 | 390 | 5,000 | 7,610 | 7,745 |
| Accrued Expenses | 2,008 | 1,757 | 1,701 | 1,559 | 1,243 |
| Other current liabilities | 13 | 388 | N/A | N/A | N/A |
| TOTAL | $6,814 | $5,878 | $10,108 | $12,435 | $10,988 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 5 | 15 |
| Other Non-Current Liabilities | 277 | 912 | 231 | 618 | 434 |
| TOTAL | $238 | $797 | $174 | $541 | $293 |
| Total Liabilities | $7,053 | $6,675 | $10,282 | $12,977 | $11,281 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,949 | 1,948 | 1,812 | 1,769 | 1,189 |
| Common Shares | 20 | 20 | 18 | 18 | 12 |
| Retained earnings | -15,851 | -14,774 | -13,559 | -13,001 | -12,210 |
| Other shareholders' equity | -3,474 | -3,696 | 711 | 776 | 874 |
| TOTAL | $-125 | $730 | $-3,141 | $-5,526 | $-5,340 |
| Total Liabilities And Equity | $6,928 | $7,405 | $7,140 | $7,450 | $5,940 |